DYNEX Technologies chose apDia to be their EXCLUSIVE distributor in the BeNeLux
We are thrilled and excited to announce that after working several years together, DYNEX Technologies chose apDia to be their EXCLUSIVE distributor in...
apDia > News room
Our international Trypanosoma b. gambiense antibody iELISA
To support medical applications worldwide, apDia is doing its part in the form of proper diagnostics! As an illustration, in Congo, screening for slee...
Breaking news! We are proud to announce that Advanced Practical Diagnostics (apDia) has successfully achieved IVDR certification covering Class B and C products! 👏🥳
This ground-breaking achievement means we comply with the IVDR (EU) 2017/746, demonstrating apDia’s commitment to designing and manufacturing truly st...
Meet our new Coworker ms. Catharina Van Opdenbosch.
After the recent leave of Sonja Ooms, Catharina will now be a part of the administration and logistics department. She will be your first contact if y...
Proud on the apDia-team and especially to our fantastic technical team !!!
Recently Joris Van Cutsem joined our technical team team: Welcome to the apDia family, we are excited to have you! Yesterday Rolf , David and Joris in...
Proud on the apDia-team , and especially to our fantastic technical team !!!
This week, they installed in 1 day , 1 Eflexis and 1 Wadiana in Belgian laboratories. One lab working manually and switching to Wadiana, the other lab...
transfusion symposium Hogent : Multidisciplinary approach to blood transfusions
apDia/Grifols was present @ transfusion symposium Hogent : Multidisciplinary approach to blood transfusions on the 16th of March 2022
Grifols Erytra Eflexis® bloodgroup analyser went live in Regionaal Ziekenhuis Heilig Hart Leuven
We are very excited to announce that the next Grifols Erytra Eflexis® bloodgroup analyser went live in the laboratories of the hospital Regionaal Ziek...
A small group of high school students dropped by apDia!
In december, a small group of high school students dropped by apDia. Taking into account all COVID-19 measures, they received information about the op...